Latest Insights - page 82 | BiopharmaTrend

On Quantum Theory, Drug Discovery, and Life Sciences Ecosystem in Spain: Interview with Dr. Enric Gibert

In contrast to molecular mechanics, which describes molecules as essentially “balls and sticks” kind of objects, taking into account only geometric parameters and repulsion/attraction between atoms, quantum mechanics describes molecules …

Continue ›››

Technology Meets Biology in Canada

Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) …

Continue ›››

The Promise of DAOs in Drug Discovery

In August, Pfizer announced it requested to join VitaDAO with a half-a-million bid. VitaDAO is a new type of decentralized autonomous organization (DAOs) built on blockchain technology. DAOs are new …

Continue ›››

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

A Market Review of DNA-encoded Libraries Technology in Drug Discovery

(Last updated: October 05, 2022) The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their internal …

Continue ›››

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Application of AI-driven Xanthos Platform for Designing Protein Degraders

First-of-its-kind AI-based Diagnostics Solutions Approved in Europe

According to the World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 - nearly every 6th death worldwide happens because …

Continue ›››

A Race For Better 3CL Inhibitors to Cure COVID-19: Copies vs. Innovators

Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related to research and development and is not intended for clinical …

Continue ›››

Ancient Material Promises To Solve Drug Delivery “Pain”

Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase access to vaccines — instead of vaccines having to be …

Continue ›››

What to Consider Before Launching a Biotech Startup in 2022?

Luciano Santollani is currently working towards his PhD at MIT developing novel cancer therapeutics, and is also working as a venture capital associate at Pillar VC. He recently wrote an …

Continue ›››